pyrazolanthrone has been researched along with Anoxia, Brain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kremer, EJ; Macrae, IM; McCabe, C; McClure, JD; Ord, EN; Shirley, R; Work, LM | 1 |
Aguirre, N; Barros-Miñones, L; Goñi-Allo, B; Hervías, I; Orejana, L; Puerta, E; Suquía, V | 1 |
2 other study(ies) available for pyrazolanthrone and Anoxia, Brain
Article | Year |
---|---|
Combined antiapoptotic and antioxidant approach to acute neuroprotection for stroke in hypertensive rats.
Topics: Animals; Anthracenes; Antioxidants; Apoptosis; Dependovirus; Enzyme Inhibitors; Genetic Vectors; Globins; Green Fluorescent Proteins; Hypertension; Hypoxia, Brain; Immunohistochemistry; Infarction, Middle Cerebral Artery; JNK Mitogen-Activated Protein Kinases; Lentivirus; Male; Nerve Tissue Proteins; Neuroglobin; Neuroprotective Agents; Oxidative Stress; Plethysmography; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; Stroke; Transduction, Genetic | 2013 |
Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate.
Topics: Administration, Oral; Animals; Anthracenes; Apoptosis; Hypoxia, Brain; Imidazoles; Male; Malonates; MAP Kinase Signaling System; Neuroprotective Agents; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; Sildenafil Citrate; Sulfonamides | 2013 |